Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2856544/7767/en/MediciNova-Announces-Abstract-Regarding-Results-of-a-Clinical-Trial-of-MN-166-ibudilast-in-Glioblastoma-Accepted-for-Presentation-at-the-2024-American-Society-of-Clinical-Oncology-.html
https://www.globenewswire.com/news-release/2024/03/26/2852845/7767/en/MediciNova-Receives-a-Notice-of-Allowance-for-a-New-Patent-Covering-MN-166-ibudilast-for-the-Treatment-of-Macular-Injury-in-Japan.html
https://www.globenewswire.com/news-release/2024/03/20/2849862/7767/en/MediciNova-Announces-Two-Abstracts-regarding-MN-001-tipelukast-and-MN-002-Accepted-for-Presentation-at-the-92nd-EAS-2024-Congress-the-Annual-Meeting-of-the-European-Atherosclerosis.html
https://www.globenewswire.com//news-release/2024/03/12/2844366/7767/en/MediciNova-Announces-New-Data-and-Results-of-MN-166-ibudilast-in-Chlorine-Gas-induced-Acute-Lung-Injury-Presented-at-the-63rd-Annual-Meeting-of-the-Society-of-Toxicology.html
https://www.globenewswire.com//news-release/2024/01/17/2810539/7767/en/MediciNova-Receives-a-Notice-of-Grant-for-a-New-Patent-Covering-MN-166-ibudilast-for-the-Treatment-of-Macular-Injury-in-China.html
https://www.globenewswire.com//news-release/2023/12/21/2800380/7767/en/MediciNova-Announces-Abstract-Regarding-MN-166-ibudilast-in-Chlorine-Gas-induced-Lung-Injury-Accepted-for-Presentation-at-the-63rd-Annual-Meeting-of-the-Society-of-Toxicology.html
https://www.globenewswire.com/news-release/2023/12/06/2792155/7767/en/MediciNova-Receives-a-Notice-of-Decision-to-Grant-for-a-New-Patent-Covering-MN-166-ibudilast-for-the-Treatment-of-Progressive-MS-in-Europe.html
https://www.globenewswire.com/news-release/2023/11/19/2782852/7767/en/MediciNova-Announces-New-Data-and-Results-of-a-Phase-2-Clinical-Trial-of-MN-166-ibudilast-in-Glioblastoma-Presented-at-the-28th-Annual-Meeting-of-the-Society-for-Neuro-Oncology.html
https://www.globenewswire.com//news-release/2023/10/27/2768137/7767/en/MediciNova-s-Collaborator-Initiates-Clinical-Development-of-a-Gene-Therapy-Product-for-the-Treatment-of-Phenylketonuria.html
https://www.globenewswire.com//news-release/2023/10/10/2757986/7767/en/MediciNova-Receives-a-Notice-of-Allowance-for-a-New-Patent-Covering-the-Combination-of-MN-166-ibudilast-and-Riluzole-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS-in-Canad.html